These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9799113)

  • 61. Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria.
    Urquiza P; Laín A; Sanz-Parra A; Moreno J; Bernardo-Seisdedos G; Dubus P; González E; Gutiérrez-de-Juan V; García S; Eraña H; San Juan I; Macías I; Ben Bdira F; Pluta P; Ortega G; Oyarzábal J; González-Muñiz R; Rodríguez-Cuesta J; Anguita J; Díez E; Blouin JM; de Verneuil H; Mato JM; Richard E; Falcón-Pérez JM; Castilla J; Millet O
    Sci Transl Med; 2018 Sep; 10(459):. PubMed ID: 30232228
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Late-onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation.
    Aguilera P; Badenas C; Whatley SD; To-Figueras J
    Br J Dermatol; 2016 Dec; 175(6):1346-1350. PubMed ID: 27086902
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases.
    Katugampola RP; Badminton MN; Finlay AY; Whatley S; Woolf J; Mason N; Deybach JC; Puy H; Ged C; de Verneuil H; Hanneken S; Minder E; Schneider-Yin X; Anstey AV
    Br J Dermatol; 2012 Oct; 167(4):901-13. PubMed ID: 22816431
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.
    Ged C; Moreau-Gaudry F; Richard E; Robert-Richard E; de Verneuil H
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):53-60. PubMed ID: 19268002
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Successful match-unrelated donor bone marrow transplantation for congenital erythropoietic porphyria (Günther disease).
    Dupuis-Girod S; Akkari V; Ged C; Galambrun C; Kebaïli K; Deybach JC; Claudy A; Geburher L; Philippe N; de Verneuil H; Bertrand Y
    Eur J Pediatr; 2005 Feb; 164(2):104-7. PubMed ID: 15703981
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Congenital erythropoietic porphyria.
    Fritsch C; Lang K; Bolsen K; Lehmann P; Ruzicka T
    Skin Pharmacol Appl Skin Physiol; 1998; 11(6):347-57. PubMed ID: 10343205
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
    Robert-Richard E; Lalanne M; Lamrissi-Garcia I; Guyonnet-Duperat V; Richard E; Pitard V; Mazurier F; Moreau-Gaudry F; Ged C; de Verneuil H
    J Gene Med; 2010 Aug; 12(8):637-46. PubMed ID: 20586119
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Congenital erythropoietic porphyria: case report and management recommendations].
    Salomone B C; Ogueta C I; Reyes V C; Durán S G; Aguirre N; Wietstruck A
    Arch Argent Pediatr; 2018 Apr; 116(2):e300-e302. PubMed ID: 29557620
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bullous skin lesions in a jaundiced infant after phototherapy: a case of congenital erythropoietic porphyria.
    Baran M; Eliaçık K; Kurt I; Kanık A; Zengin N; Bakiler AR
    Turk J Pediatr; 2013; 55(2):218-21. PubMed ID: 24192686
    [TBL] [Abstract][Full Text] [Related]  

  • 70. C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria.
    Frank J; Wang X; Lam HM; Aita VM; Jugert FK; Goerz G; Merk HF; Poh-Fitzpatrick MB; Christiano AM
    Ann Hum Genet; 1998 May; 62(Pt 3):225-30. PubMed ID: 9803266
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hematologic aspects of the porphyrias.
    Sassa S
    Int J Hematol; 2000 Jan; 71(1):1-17. PubMed ID: 10729988
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fluorescence-based selection of retrovirally transduced cells in congenital erythropoietic porphyria: direct selection based on the expression of the therapeutic gene.
    Fontanellas A; Mazurier F; Belloc F; Taine L; Dumain P; Morel C; Ged C; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 1999; 1(5):322-30. PubMed ID: 10738549
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gene transfer of the uroporphyrinogen III synthase cDNA into haematopoietic progenitor cells in view of a future gene therapy in congenital erythropoietic porphyria.
    Mazurier F; Moreau-Gaudry F; Salesse S; Barbot C; Ged C; Reiffers J; de Verneuil H
    J Inherit Metab Dis; 1997 Jun; 20(2):247-57. PubMed ID: 9211197
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The diagnosis of acute intermittent porphyria. Usefulness and limitations of the erythrocyte uroporphyrinogen I synthase assay.
    Bottomley SS; Bonkowsky HL; Kreimer-Birnbaum M
    Am J Clin Pathol; 1981 Aug; 76(2):133-9. PubMed ID: 7270494
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression.
    Aizencang G; Solis C; Bishop DF; Warner C; Desnick RJ
    Genomics; 2000 Dec; 70(2):223-31. PubMed ID: 11112350
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease.
    Sassa S; Granick S; Bickers DR; Bradlow HL; Kappas A
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):732-6. PubMed ID: 4522787
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The prenatal presentation of congenital erythropoietic porphyria: report of two siblings with elevated maternal serum alpha-fetoprotein.
    Lazebnik N; Lazebnik RS
    Prenat Diagn; 2004 Apr; 24(4):282-6. PubMed ID: 15065102
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
    Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
    Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.
    Géronimi F; Richard E; Lamrissi-Garcia I; Lalanne M; Ged C; Redonnet-Vernhet I; Moreau-Gaudry F; de Verneuil H
    J Mol Med (Berl); 2003 May; 81(5):310-20. PubMed ID: 12721665
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis.
    Ged C; Moreau-Gaudry F; Taine L; Hombrados I; Calvas P; Colombies P; De Verneuil H
    Prenat Diagn; 1996 Jan; 16(1):83-6. PubMed ID: 8821859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.